Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Allovir's CEO, Diana Brainard, sold 1,489 shares of common stock on July 2, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On July 2, 2024, Diana Brainard, the CEO of Allovir, Inc., sold 1,489 shares of the company's common stock.
- The sale was executed at a price of $0.72 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Brainard directly owns 782,982 shares of Allovir common stock.
Sentiment
Score: 6
Explanation: The document is neutral. It simply reports a stock sale to cover tax obligations, which is a routine event.
Industry Context
Executive stock sales to cover tax obligations are a common practice and do not necessarily indicate a negative outlook on the company's future.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 07/02/2024 | Date of stock sale transaction. |
| 07/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.